Editor: Paraskevi Theofilou

Outcomes Assessment in End - Stage Kidney Disease Measurements and Applications in Clinical Practice

Personal Book: US $59 Special Offer (PDF + Printed Copy): US $148
Printed Copy: US $119
Library Book: US $236
ISBN: 978-1-60805-736-8
eISBN: 978-1-60805-735-1 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080573511130101

Introduction

With an increase of the population of elderly people in modern society due to advances in medicine and healthcare facilities, there is also an increase in the incidence and duration of chronic illnesses. Similarly, advanced age is considered a significant determinant of depression and poor quality of life. Additionally, the provision of therapies relevant to chronic diseases addresses the issues beyond the concept of cure, bringing to the center the need for a dignified quality of life of patients. An increased interest in quality of life is observed in patients who suffer from chronic diseases, including those with end-stage kidney disease (ESKD). End-stage kidney disease patients have a high burden of disease affecting their quality of life and dramatically shortening their life expectancy. Therefore, exploring quality of life issues among such patients becomes an essential task in the management of this population. This volume is written by researchers with a well-rounded understanding of the characteristics and impact of ESKD and provides a penetrating practical discussion to date of alternative approaches for comprehensively measuring the burden of end-stage kidney disease. Outcomes Assessment in End-Stage Kidney Disease focuses on the impact of this complex and exacting condition on patients and those that care for them. It also examines the economic impact of ESKD and the healthcare policy implications of this disease. It also brings comprehensive and thoughtful insights into the issues confronted by patients with ESKD to readers interested in nursing or medical caregiving, geriatrics and health psychology.

Indexed in: Book Citation Index, Science Edition, EBSCO.

Preface

Modern societies include increasing proportions of elderly people, with a resulting increase in the incidence and duration of chronic illnesses. Similarly, advanced age is considered a significant determinant of depression and poor quality of life. Additionally, the provision of therapies relevant to chronic diseases addresses the issues beyond the concept of cure, bringing to the center the need for a dignified quality of life of patients. An increased interest in quality of life is observed in patients who suffer from chronic diseases, including those with end-stage kidney disease. End-stage kidney disease patients have a high burden of disease affecting their quality of life and dramatically shortening their life expectancy. Therefore, exploring quality of life becomes an essential task in the management of this population. This volume provides a penetrating practical discussion to date of alternative approaches for comprehensively measuring the burden of end-stage kidney disease.

Disclosure

The part of text has been taken from the article J Clin Med Res. 2011 3(3): 132–138. (www.ncbi.nlm.nih.gov/pmc/articles/PMC3138410/)

Paraskevi Theofilou
Sotiria Hospital for Thoracic Diseases,
Athens
Greece

&

Center for Research and Technology
Department of Kinesiology
Health & Quality of Life Research Group
Trikala
Thessaly
Greece